2022-02-28

[#DIV28SUPER] Call for Nominations - Psychologist sought for position on APA clinical practice guideline advisory steering committee

 

Call for Nominations - Psychologist sought for position on APA clinical practice guideline advisory steering committee

Deadline for nominations is April 1, 2022

Dear Colleagues,

Nominations are invited for one position on the Advisory Steering Committee for Development of Clinical Practice Guidelines of the American Psychological Association (APA). The Advisory Steering Committee (ASC) oversees APA's process for clinical practice guideline development, including selection of topics for guidelines, recommendation of members for guideline development panels, and planning and assessment of guideline development processes. The term for the new position will begin in spring 2022, and the deadline for submitting nominations is April 1, 2022. Individuals are asked to self-nominate. 

Click here for more information and submission instructions.

Please distribute to your networks.

Thank you,

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

2022-02-25

[#DIV28SUPER] Fwd: [DIV37] Register now! Suicide Prevention in Indigenous Communities: A Virtual Workshop



---------- Forwarded message ---------
From: Mary Ann McCabe <mamccabe@cox.net>
Date: Fri, Feb 25, 2022, 9:27 AM
Subject: [DIV37] Register now! Suicide Prevention in Indigenous Communities: A Virtual Workshop
To: <DIV37@lists.apa.org>


 

 

 

 

From: NASEM Health and Medicine <HMDnews-list@nas.edu>
Sent: Thursday, February 24, 2022 3:00 PM
To: Andrada, Alexandra <AAndrada@nas.edu>
Subject: Register now! Suicide Prevention in Indigenous Communities: A Virtual Workshop

 

 

Register Now! 
 

Suicide Prevention in Indigenous Communities:
A Virtual Workshop


Webinar 1: Strength and Protective Factors | April 22, 2022 11:00am-4:00pm ET
Webinar 2: May 13, 2022 11:00am-4:00pm ET
Webinar 3: June 10, 2022 11:00am-4:00pm ET

 

The National Academies Forum on Mental Health and Substance Use Disorders is hosting a virtual workshop series exploring the current scope of activities, gaps, challenges, and opportunities to prevent death by suicide in Indigenous communities. 

Webinar 1, on April 22, 2022 from 11:00 AM – 4:00 PM ET, will focus on strength and protective factors found in Indigenous populations to combat suicide. Sessions will:

  • Examine the differences between and among groups and tribes geographically, culturally, and linguistically 
  • Emphasize the importance of strength-based work and tribal sovereignty 
  • Discuss resilience processes that include protective factors including Indigenous determinants, healing ceremonies, and risk factors including and considering social determinants of health
  • Highlight cultural knowledge, practice, ceremony, and how this acts in parallel to behavioral health intervention and suicide prevention, and contributes to strength factors
  • Provide an opportunity for attendees to join other experts during a 20-minute breakout session 

 

 

 

This webinar invites all policy leaders, clinicians, practitioners, researchers, and community members interested in joining a conversation with workshop presenters to discuss current practices and ideas for future implementation to better suicide prevention strategies in Indigenous populations to our breakout sessions from 2:45 PM – 3:05 PM ET. Register here by April 15, 2022 to join the discussion.

*Attendees who wish to join the breakout session should register for both the webinar itself from 11 AM-4 PM ET, and the breakout sessions from 2:45-3:05 PM ET. 

This workshop is sponsored by the Office of the Assistant Secretary for Health, the Centers for Disease Control and Prevention, National Institute of Mental Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Substance Abuse and Mental Health Services Administration. For more information please visit our website.

 

 

Help Spread the Word!

Share on Twitter: Save the date! Join @NASEM_Health on April 22 for a webinar exploring strength and protective factors in Indigenous communities to combat suicide. Register now: https://bit.ly/3JArqXt

 

 

Facebook

Twitter

LinkedIn

YouTube

National Academies of Sciences, Engineering, and Medicine

View this email in your browser

 

Copyright © 2021 National Academy of Sciences, All rights reserved.
You are receiving this because you opted in to get emails from the Health and Medicine Division.

Our mailing address is:
500 Fifth Street NW
Washington, DC 20001

The Health and Medicine Division continues the consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM). Visit us at http://nationalacademies.org/HMD

If you no longer want to receive emails from this list, update your subscription preferences.
If you no longer want to receive any email updates from the Health and Medicine Division, unsubscribe




This email was sent to AAndrada@nas.edu
why did I get this?    unsubscribe from this list    update subscription preferences
National Academy of Sciences · 500 Fifth Street NW · Washington, DC 20001 · USA

For more information about APA Division 37: Society for Child and Family Policy and Practice, please visit our website at http://www.apa.org/divisions/div37/ Click on this link to unsubscribe from this list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2022-02-24

[#DIV28SUPER] T32 positions available at the University of Kentucky

The University of Kentucky NIDA-funded T32 (T32DA0035200; Research Training on Drug Abuse Behavior) will be accepting applications for six (6) training positions (three [3] pre-doctoral and three [3] post-doctoral slots). Please recall only US citizens or permanent residents are eligible. NIH reviews the training grant with respect to a demonstration of the ability to recruit excellent trainees who are from demographic groups underrepresented in science. If you know of someone who is interested and eligible, please encourage them to apply. Please also forward this message to anyone who might be interested. 

We are asking the proposed faculty supervisor(s) of the applicants to gather all the documents requested in the attached document. Please assemble these materials into a single PDF and email to Dr. Craig Rush (crush2@uky.edu) by noon Eastern on April 15, 2022. Please use the following file-naming conventions: LastName_FirstName_Pre_2021 for pre-doctoral applications and LastName_FirstName_Post_2021 for post-doctoral applications.  For a list of T32 training faculty supervisors, please also contact Dr. Rush. A selection committee will then rate the applicants and the most qualified applicants will be offered the positions. Priority will be given to those candidates who propose to work on NIDA-funded or NIDA-related projects. We will complete the selection process during April. 

 

Thank you in advance for encouraging qualified candidates to apply. Please feel free to contact Dr. Rush if you have any questions. 



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383


Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science
Clinical Research Support Office

Associate Director for Clinical Research
Substance Use Priority Research Area



STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2022-02-23

[#DIV28SUPER] We are Hiring: Postdoctoral Trainee interested in opioid human clinical trials

Hello colleagues,

Please share this postdoctoral training opportunity for persons interested in rigorous opioid research trials. Contact me directly with interest or questions

Kelly Dunn, kdunn9@jhmi.edu; 410-550-2254.


 


---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Position Announcement: JHU School of Public Health, Dept. of Mental Health, Chair

Bloomberg Centennial Professor and Chair, Department of Mental Health

The Johns Hopkins Bloomberg School of Public Health invites applications for the Bloomberg Centennial Professor and Chair of the Department of Mental Health. The successful applicant will have an outstanding record of academic and research accomplishments, demonstrated leadership and administrative abilities, a public health perspective on mental health, and a compelling vision for the Department. The Department of Mental Health seeks to advance understanding of mental health and substance use disorders, with a strong focus on etiology and the development and implementation of programs and policies to advance public mental health and health equity in a range of community, school, and workplace settings. The department brings together researchers and practitioners from multiple disciplines to understand, prevent, and treat mental health and substance use conditions. Founded over 60 years ago, the Department is still the only Department of Mental Health in a school of public health. It has 57 full time faculty, 69 doctoral and master's students and multiple post-doctoral fellows who are working domestically and internationally across a diverse set of disciplines including epidemiology, biostatistics, psychology, sociology, psychiatry, and health policy applied to critical public mental health challenges across the life course from developmental disabilities through adolescent and adult mental health, severe mental illness, and cognitive aging. The department is one of 10 academic departments at the Bloomberg School. The School is consistently ranked among the top schools of public health in the country with more than 870 full-time faculty and 2,700 graduate-level students. The main campus of the School is located on the medical campus in East Baltimore. Both the East Baltimore campus and the broader University support a collaborative and highly interactive environment with a superb research infrastructure. The Johns Hopkins University is committed to equal opportunity for its faculty, staff, and students. To that end, the university does not discriminate on the basis of sex, gender, marital status, pregnancy, race, color, ethnicity, national origin, age, disability, religion, sexual orientation, gender identity or expression, veteran status, military status, immigration status, or other legally protected characteristic. The university is committed to providing qualified individuals access to all academic and employment programs, benefits, and activities on the basis of demonstrated ability, performance, and merit without regard to personal factors that are irrelevant to the program involved.

Applications should include 1) curriculum vitae; 2) statement of academic interest and vision of leadership; and 3) statement of demonstrated commitment to the principles of inclusion, diversity, anti-racism, and equity (IDARE) in scholarship, teaching, policy, and practice, and ways to continue to promote and advance these principles in their leadership of the Department. Review of candidates will begin April 1, 2022. Please direct all questions about this search to Susan Williams, Administrative Specialist, at swilli94@jhu.edu.
Applications should be submitted to: http://apply.interfolio.com/102322


---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030


 


********************************************************************************

2022-02-22

[#DIV28SUPER] DEADLINE EXTENDED: MARCH 22 | Apply Now for Summer Training and $30,000 Research Grant - 2022 HIV/Drug Abuse Prevention Research Ethics Training Institute

SUMMER TRAINING & RESEARCH FUNDING FOR
EARLY CAREER INVESTIGATORS*

Apply to become a fellow of the NIDA-funded
Director & Principal Investigator (R25DA031608)
  • Attend two summer training institutes: July 11-18, 2022 (In-Person, NYC) and July 2023 (TBD) with fully funded travel and lodging 
  • Receive a $30,000 grant to conduct a mentored research study that will contribute to evidence-based HIV & drug abuse research ethics practice 
  • Join an international network of scholars examining current challenges in HIV & drug abuse research ethics
* Our hope is to offer in-person training for Summer 2022. However, given the ongoing COVID-19 pandemic, we will offer hybrid (virtual) formats for those who are unable to attend in person. Any in-person training activities will be in compliance with New York State, New York City, and Fordham University policies on COVID-19 safety.

Institute alumni have published findings from their Institute-funded research in high impact journals, incorporated findings as pilot data for successful NIH grant applications, and have become recognized as experts in the responsible conduct of HIV and drug abuse research. To see our trainees' accomplishments, visit our publications page or the "HIV/AIDS & Drug Abuse Research Ethics" online collection at www.researchethics.net.

HOW AND WHEN TO APPLY
Visit www.fordham.edu/RETIapply for the application requirements and form, or contact Rimah Jaber at ethicsinst@fordham.edu for more information. Applications are due March 22, 2022. Applicants will be notified of award decisions by April 30, 2022.

--
Celia B. Fisher, PhD.
Marie Ward Doty University Chair in Ethics
Professor of Psychology, 
Fordham University, Dealy hall
441 East Fordham Road
Bronx, NY 10458
e. Fisher@fordham.edu  t. (718)817-3793  f. (718)817-0731
Administrative Assistant Lori Merone, lmerone@fordham.edu (718) 817-0926
HIV/Drug Abuse Program Administrator Rimah Jaber, ethicinst@fordham.edu (718) 817-0927
Follow the Ethics Center on Twitter and Facebook: @FordhamEthics and on our blog ethicsandsociety.org
Preferred pronouns: she, her, hers

   

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2022-02-21

[#DIV28SUPER] Quick Favor (Rich) ❤️

Hi, 

How are you doing? I need a favor from you. Do you shop on Amazon? Wondering if you can help me place an order.

Thanks.
Rich Mucowski


[#DIV28SUPER] Fw: Register Today! Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws - A Workshop

Hello colleagues,

Please see below a webinar focused on methadone prescribing practices, with a hopeful emphasis on expanding access to methadone.

Warm regards,
Kelly

---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030



 
Register Today
 
Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws:
A Workshop


March 3, 2022 | 9:30am-5:00pm ET
March 4, 2022 | 9:30am-4:30pm ET
 
Opioid use disorder (OUD)—a chronic brain disease caused by prolonged use of prescription opioids, heroin, or other illicit opioids—imposes heavy costs on individuals, their families, and society. Methadone is one of three safe and highly effective medications that are approved by the U.S. Food and Drug Administration to treat OUD; however, stringent laws and regulatory policies pose substantial barriers to provision of and access to quality treatment. 

On March 3-4, 2022, the National Academies of Sciences, Engineering, and Medicine'sBoard on Health Sciences Policy and Board on Health Care Services, and National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic will host a public workshop bringing together experts and key stakeholders to examine the current federal regulatory and legal landscape regarding provision of and access to methadone for the treatment of opioid use disorder. 

Invited presentations and discussions will be designed to:
  • Examine current federal regulations governing methadone treatment services, including the current COVID-19 emergency regulatory relief; 
  • Discuss the impact of these regulations relative to other factors affecting treatment services; 
  • Explore potential options for modifying federal regulations and laws to expand access to quality treatment with methadone; and
  • Explore state laws that may conflict with federal regulations. 
This workshop is sponsored by the Office of National Drug Control Policy, Executive Office of the President.

For more information, including the planning committee slate and biographies, please visitour website.
 


--
Kelly Dunn, Ph.D., MBA
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Science
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

2022-02-15

[#DIV28SUPER] NIDA Neuroscience Update, February 15, 2022

Table of Contents

I.                     Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)

II.                   Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

III.                  The Virtual Short Course on the Genetics of Addiction and In-Person Research Experiences for Faculty and Student Teams Underrepresented in Science

IV.                 Brain Behavior Quantification and Synchronization (BBQS) workshop

----

 

I.  Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)

The purpose of this funding opportunity announcement is to support research examining the potential contributions of mobile DNA elements and addictive substances in HIV integration, reservoir formation, and maintenance in the brain. NIDA is specifically interested in studies exploring the contributions of molecular, genetic, and epigenetic factors in HIV integration, reservoir formation, and maintenance in microglia and/or the brain in the context of addiction.

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

----

 

II.  Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html

---

 

III.             The Virtual Short Course on the Genetics of Addiction and In-Person Research Experiences for Faculty and Student Teams Underrepresented in Science

https://www.jax.org/education-and-learning/education-calendar/2022/february/addiction-genetics#

This unique training experience combines our Annual Short Course in a virtual format with the opportunity for mentored research experiences: the goal is to support and expand a diverse community of academics in their pursuit and advancement of addiction-related education, research, and careers. The research experiences are designed for teams of faculty, postdoctoral fellows, and undergraduate and graduate students underrepresented in science for training and mentored research projects utilizing advanced methods and resources for addiction genetics.

Each day of the course will be held from 12pm-2pm (Eastern Time) M/W/F and focus on a general topic area. Sessions will be recorded and made available to registered attendees to view on-demand for two months following the course.

 

Course funding: 1R25DA051342 (NIH/NIDA; E. Chesler, PI); 5R13DA052199 (NIH/NIDA; E. Chesler, PI)

 

ENROLL IN THE ONLINE COURSE:

https://web.cvent.com/event/98db01c0-f610-41c7-9251-dfd791c34fb8/regProcessStep1

 

----

 

IV. Brain Behavior Quantification and Synchronization (BBQS) workshop

https://event.roseliassociates.com/bbqs-workshop/

The BRAIN Initiative invites you to attend the Brain Behavior Quantification and Synchronization (BBQS) workshop, hosted by the NIH Brain Initiative. The workshop will be held virtually on March 1-2, 2022 from 1:00 – 5:30 pm ET. The workshop will bring together innovators in bioengineering, computational science and informatics, cognitive neuroscience (both human and animal studies), evolutionary biology and ethology, social sciences, and ethics with the objective of identifying advances in research necessary for a more comprehensive understanding of behavior.

 

For more information and to REGISTER, click here.

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L